mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |